China’s stealth military device, Singapore’s grant for Taylor Swift, Hong Kong talent scheme earners: SCMP’s 7 highlights of the week

The median monthly income of professionals recruited under Hong Kong’s leading talent admission scheme is HK$50,000 (US$6,390), more than double what locals are earning, the city’s leader has revealed.

3. ‘Smart’ move: Singapore’s grant for Taylor Swift earns praise and brickbats

Singer Taylor Swift performs at her concert for the international “The Eras Tour” in Tokyo on February 7. Photo: Reuters

Singapore’s decision to pay American pop star Taylor Swift a grant to perform in the city state allegedly on an exclusivity clause has divided online users.

4. As China powers ahead on EVs, battery plant health risks raise a red flag

Illustration: Davies Christian Surya

China’s electric car market is No 1 in the world but factory findings by health authorities around the country have now shed light on the lesser-known health impact of the rapidly developing industry.

5. Dark history of Malaysia’s Chinese villages underscores fury over Unesco bid

A proposal by the Malaysian government to seek Unesco heritage status for a cluster of “New Villages” in Selangor has sparked heated debate between the Malay and Chinese communities over whose culture is pre-eminent in a country where historical racial wounds are still festering.

6. ‘Hong Kong employer of late Filipino helper asked to pay HK$580,000 for damages’

A Hong Kong employer has been sued for damages and is asked to pay more than HK$580,000 (US$74,155) in compensation for depriving her late Filipino domestic helper of food and firing her after her cancer diagnosis, a court has heard.

7. How statins, used to lower cholesterol, could also lower risk of dementia

Recent studies are pointing to statins’ positive impact on brain health. Photo: Shutterstock

Recent research suggests a drug more than 200 million people worldwide take for their heart health might prevent dementia, or delay its progress.


This website uses cookies. By continuing to use this site, you accept our use of cookies.